Gain Therapeutics
GANX
GANX
14 hedge funds and large institutions have $8.95M invested in Gain Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$501K | |
| 2 | +$303K | |
| 3 | +$116K | |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$100K |
| 5 |
Millennium Management
New York
|
+$95.2K |
Top Sellers
| 1 | -$982K | |
| 2 | -$694K | |
| 3 | -$340K | |
| 4 |
Jane Street
New York
|
-$339K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$232K |